BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31085101)

  • 21. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
    Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
    Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease.
    Van Broeck B; Chen JM; Tréton G; Desmidt M; Hopf C; Ramsden N; Karran E; Mercken M; Rowley A
    Br J Pharmacol; 2011 May; 163(2):375-89. PubMed ID: 21232036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.
    Sadleir KR; Kandalepas PC; Buggia-Prévot V; Nicholson DA; Thinakaran G; Vassar R
    Acta Neuropathol; 2016 Aug; 132(2):235-256. PubMed ID: 26993139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of Bdnf gene deficiency to the memory impairment and brain pathology of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Rantamäki T; Kemppainen S; Autio H; Stavén S; Koivisto H; Kojima M; Antila H; Miettinen PO; Kärkkäinen E; Karpova N; Vesa L; Lindemann L; Hoener MC; Tanila H; Castrén E
    PLoS One; 2013; 8(7):e68722. PubMed ID: 23844236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.
    Peng S; Garzon DJ; Marchese M; Klein W; Ginsberg SD; Francis BM; Mount HT; Mufson EJ; Salehi A; Fahnestock M
    J Neurosci; 2009 Jul; 29(29):9321-9. PubMed ID: 19625522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.
    Hashimoto T; Fujii D; Naka Y; Kashiwagi-Hakozaki M; Matsuo Y; Matsuura Y; Wakabayashi T; Iwatsubo T
    Acta Neuropathol Commun; 2020 Dec; 8(1):212. PubMed ID: 33287899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early intraneuronal amyloid triggers neuron-derived inflammatory signaling in APP transgenic rats and human brain.
    Welikovitch LA; Do Carmo S; Maglóczky Z; Malcolm JC; Lőke J; Klein WL; Freund T; Cuello AC
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6844-6854. PubMed ID: 32144141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease.
    Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R
    PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.
    Ginsberg SD; Malek-Ahmadi MH; Alldred MJ; Chen Y; Chen K; Chao MV; Counts SE; Mufson EJ
    Neurobiol Dis; 2019 Dec; 132():104540. PubMed ID: 31349032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
    Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.
    Coma M; Serenó L; Da Rocha-Souto B; Scotton TC; España J; Sánchez MB; Rodríguez M; Agulló J; Guardia-Laguarta C; Garcia-Alloza M; Borrelli LA; Clarimón J; Lleó A; Bacskai BJ; Saura CA; Hyman BT; Gómez-Isla T
    Neurobiol Dis; 2010 Jun; 38(3):482-91. PubMed ID: 20149872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the plant viral protease NIa in the brain of a mouse model of Alzheimer's disease mitigates Aβ pathology and improves cognitive function.
    Kim TK; Han HE; Kim H; Lee JE; Choi D; Park WJ; Han PL
    Exp Mol Med; 2012 Dec; 44(12):740-8. PubMed ID: 23172351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
    Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
    Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.